CRAF
AMENDMENT CORRESPONDENCE ENTERED
05/09/2024
Back to search
Official data from USPTO
SCG CELL THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
05/09/2024
Trademark type
Combined
Nice classes
5
Filing date
01/19/2022
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
05/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/19/2021
First use in commerce
11/19/2021
Drawing code
3
Owner type
16
Owner location
Singapore, SG
Examiner
MICKLEBURGH, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "SCG CELL THERAPY",on the left there is a circle design surrounded by three water drop designs and three circle designs.
Holders and representatives
Holders
SCG CELL THERAPY PTE. LTD.
Representatives
SCG CELL THERAPY PTE. LTD.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Immunostimulants; Anti-cancer preparations; Biological preparations for the treatment of cancer; Blood for medical purposes; Cellular function activating agents for medical purposes; Diet pills; Human vaccine preparations; Living cells for medical use; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparationsantivirals; Tumor suppressing agents
Publications
History of USPTO decisions and trademark events.
17 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/30/2023
PUBO
PUBLISHED FOR OPPOSITION
05/30/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/25/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/25/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/31/2022
GNRT
NON-FINAL ACTION E-MAILED
10/31/2022
CNRT
NON-FINAL ACTION WRITTEN
10/31/2022
DOCK
ASSIGNED TO EXAMINER
10/28/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2022
NWAP
NEW APPLICATION ENTERED
01/22/2022
Continuous trademark protection
Get notified about every new filing that threatens SCG CELL THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.